Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Bristol-Myers Squibb Stories

2013-06-21 12:49:39

One of the largest clinical trials done in infants with congenital (present at birth) heart diseases, published in the New England Journal of Medicine, shows that the increasingly common practice of using the drug clopidogrel (Plavix®) to reduce shunt-related blood flow issues is not effective in the dose studied. “Once again, pediatric-specific research shows that newborns and infants are not little adults," said David Wessel, MD, Chief Medical Officer, Children's National Medical...

2013-06-21 04:22:23

SAN DIEGO and IRVINE, Calif., June 21, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTCQB: SRNE; Sorrento) and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq(TM)) and IG-004 (TOCOSOL® paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine (CLINAM) and the European Technology Platform on Nanomedicine (ETPN) in Basel, Switzerland on June 23( )-...

2013-06-18 08:37:30

HONG KONG, June 18, 2013 /PRNewswire/ -- Insiderslab.com has released insider trading reports for the following stocks: Bank of America (NYSE:BAC), Hewlett-Packard (NYSE:HPQ), Bristol Myers Squibb (NYSE:BMY), Annaly Capital Management (NYSE:NLY), Walt Disney (NYSE:DIS), and American Capital Agency (NASDAQ:AGNC). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report...

2013-06-17 12:28:27

NEW YORK, June 14, 2013 /PRNewswire/ -- The law firm of Rheingold, Valet, Rheingold, McCartney & Giuffra LLP has just commenced what is believed to be the first suit in New York for the development of pancreatic cancer in the user of two common anti-diabetic drugs, Byetta and Janumet (also known as Januvia). The suit, by Staten Island resident Robert Cataletto, was filed on June 14, 2013 Cataletto v. Amylin Pharmaceuticals, LLC, et al., E.D.N.Y. CV 13-3411. Mr. Cataletto...

2013-06-14 08:25:32

PRINCETON, N.J. and NANJING, China, June 14, 2013 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) and Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company in China, today announced that the companies have expanded their strategic relationship formed in 2010. The companies have agreed to collaborate in China on the development and commercialization of the subcutaneous (SC) formulation of Bristol-Myers Squibb's biologic medicine, Orencia® (abatacept), for the...

2013-06-12 08:29:39

Study Meets Primary Endpoint of Progression-Free Survival THOUSAND OAKS, Calif., June 12, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the Phase 3 TRINOVA-1 trial evaluating trebananib plus paclitaxel versus placebo plus paclitaxel in recurrent ovarian cancer met its primary endpoint of progression-free survival (PFS). A statistically significant difference was observed in PFS with a 34 percent reduction in the risk of disease progression or death (HR = 0.66, 95...

2013-06-12 08:28:30

-- Galectin Therapeutics and Earle A. Chiles Research Institute - NORCROSS, Ga., June 12, 2013 /PRNewswire-USNewswire/ -- Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that preclinical studies have shown that combining the galectin inhibitor GR-MD-02 with monoclonal antibodies that function as immune checkpoint blockade inhibitors enhance shrinkage of prostate and breast cancer...

2013-06-11 20:23:46

PARIS, June 11, 2013 /PRNewswire/ -- AMPLE Study results highlighted during a press conference at the European League Against Rheumatism (EULAR) Annual congress - Year 2 data shows similar efficacy between ORENCIA plus methotrexate (MTX) and Humira plus MTX, consistent with the year 1 result which demonstrated comparable efficacy based on a non-inferiority endpoint for ACR 20 response - Radiographic...

2013-06-07 08:26:59

HONG KONG, June 7, 2013 /PRNewswire/ -- Pennystocksinsiders.com (PSI) released insider trading news for the following active stocks and penny stocks: Gilead Sciences (NASDAQ:GILD), Bristol Myers Squibb (NYSE:BMY), Home Depot (NYSE:HD), EMC (NYSE:EMC), Lowe's (NYSE:LOW), and Juniper (NYSE:JNPR). (Logo: http://photos.prnewswire.com/prnh/20130417/HK96241LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report...

2013-06-06 18:31:08

The CatSalut protocol implies the immediate transfer of a patient who suffers a heart attack to a center with hemodynamic unit The Cardiovascular Research Laboratory of the IDIBELL led by the cardiologist of the Bellvitge University Hospital José Luis Ferreiro has conducted a study on the effect of antiplatelet drugs given to high risk patients suffering from acute myocardial infaction (heart attack) in the context of the Infarction Code. The study concludes that when...